Keith Regnante, CFO: Keros Therapeutics KROS Sell · Filed 23/06/12

Trade details

Type: Insider sale
Amount: $720,164.79
Shares · price: 15,993 sh · $45.03 a share
Held after: 4,007 sh
Stock: Keros Therapeutics KROS
Person: Keith RegnanteCFO
Trade date: 23/06/09
Filed: 23/06/12
Days to filing: 3 days

Sold 80.0% of holdings

Share of holding sold: 80.0%

Keros Therapeutics trades, last 26 weeks

What else happened in Keros Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/10~23/07/09

Keith Regnante's recent trades

Keith RegnanteCFO
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$77.5K
4,739 sh
$77.5K
Filed 02/20
Traded 02/18
Keith RegnanteCFO
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$1.8M
40,000 sh
$1.8M
Filed 25/01/24
Traded 24/01/04
Keith RegnanteCFO
SellKeros Therapeutics
Sell
Keros Therapeutics
KROS
$1.8M
40,000 sh
$1.8M
Filed 24/01/08
Traded 23/11/04
Keith RegnanteCFO
Sell10b5-1 planKeros Therapeutics
Sell10b5-1 plan
Keros Therapeutics
KROS
$824.6K
17,301 sh
$824.6K
Filed 23/06/12
Traded 23/06/08
Keith RegnanteCFO
Sell10b5-1 planKeros Therapeutics
Sell10b5-1 plan
Keros Therapeutics
KROS
$131.3K
2,699 sh
$131.3K
Filed 23/06/12
Traded 23/06/08